CardioComm Solutions, Inc.
EKGGFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$908878
P/E Ratio—
52W High$0.011
52W Low$0.003
CardioComm Solutions, Inc. (EKGGF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EKGGF · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.27M | $0.53M | $0.88M | $1.00M | $0.68M |
| Cost of Revenue | $0.50M | $0.02M | $0.13M | $0.26M | $0.05M |
| Gross Profit | ($0.23M) | $0.51M | $0.75M | $0.74M | $0.64M |
| Gross Margin %(computed) | -84.41% | 96.42% | 85.43% | 74.35% | 93.40% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.01M |
| G&A Expenses | $0.67M | $0.64M | $0.23M | $0.21M | $0.81M |
| Total Operating Expenses | $0.34M | $0.77M | $0.95M | $0.81M | $0.76M |
| Operating Income | ($0.57M) | ($0.26M) | ($0.12M) | $0.01M | ($0.14M) |
| Operating Margin %(computed) | -210.31% | -49.59% | -13.20% | 0.63% | -20.81% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.05M | $0.04M | $0.03M | $0.02M | $0.03M |
| Income Before Tax | ($0.53M) | ($0.19M) | ($0.10M) | ($0.00M) | $0.00M |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.53M) | ($0.19M) | ($0.10M) | ($0.00M) | $0.00M |
| Net Margin %(computed) | -194.55% | -36.94% | -11.11% | -0.25% | 0.04% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.00 | $-0.00 | $0.00 | $0.00 |
| Wtd Avg Shares | 194.86M | 171.20M | 151.36M | 150.82M | 149.15M |
| EBITDA | ($0.54M) | ($0.13M) | ($0.04M) | $0.05M | $0.06M |
| EBITDA Margin %(computed) | -199.77% | -24.24% | -5.05% | 5.12% | 8.59% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · CAD · M
Explore more CardioComm Solutions, Inc. data
About CardioComm Solutions, Inc. (EKGGF) Income Statement
CardioComm Solutions, Inc. (EKGGF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EKGGF reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -84.41%), and net income of ($0.00B) — a net profit margin of -194.55%.
Frequently asked questions
EKGGF · 4 questionsCardioComm Solutions, Inc. (EKGGF) reported revenue of $0.00B for 2025, down 48.4% year-over-year.
EKGGF revenueEKGGF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15